Back in 2015, former President Barack Obama launched the Precision Medicine Initiative, which stood at a whopping $215 million, to great fanfare. Eight years since then, the U.S. health care system remains futile in its attempt to overturn the sluggish pace of widespread adoption of these technologies.
Why is that? The answer is simple: it’s the money. The money needed for understanding our genome and our cells at molecular level. The money to use new technologies to achieve precision health and…
